Ukko

Biotechnology, Food and Beverage, Health Care
Founded in 2016-01-01
Palo Alto, California, United States
For Profit

About Ukko

Ukko is a biotech company improving the lives of millions that suffer from food allergies and disorders. The company's computational engineering platform re-designs food allergens into safe and effective therapeutics that will become best-in-class allergy therapy. Ukko is creating a comprehensive, clinically validated map of the molecular structure of food allergies, revealing critical information about the biological mechanisms that govern human-food interactions. They use the platform to create new versions of proteins that do not elicit an immune response based on this map. These proteins enable a completely new approach to treating protein-based allergies.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 47699997 USD
  • Last Funding: 40000000 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

Ukko actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Food and Beverage, Health Care

Headquarters: Palo Alto, California, United States